Gall Bladder Status Among Children With Chronic Haemolytic Anemia
NCT03533322 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2018-07-31
Summary
Gall bladder status among children with chronic haemolytic anemia attending to Assuit University Children Hospital.
Hemolysis is defined as the premature destruction of red blood cells (RBCs) (a shortened RBC life span). Anemia results when the rate of destruction exceeds the capacity of the marrow to produce RBCs. Normal RBC survival time is 110-120 days (half-life: 55-60 days), and thus, approximately 0.85% of the most senescent RBCs are removed and replaced each day.
Patients with chronic haemolytic anemia are subjected to many complications of chronic haemolytic anemia e.g anemic heart failure, complications of blood transfusion as hepatitis and AIDS, hypersplenism, haemosiderosis ,among them there is incidence of gallbladder stone formation.
This work aims to a) to determine the prevalence of gall bladder diseases among patient with chronic haemolytic anemia.
b) to determine the risk factors of gall bladder diseases among patients with chronic haemolytic anemia.
Conditions
- Gall Bladder Disease
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
abelatif abdelmoez, professor · assiut universitypediatric hospital
-
shereen galal, assistprof · assiut universitypediatric hospital
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2019-10-01
- Completion
- 2019-10-01
More Related Trials
-
Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
NCT00050115 ·Status: COMPLETED
-
National Exhaustive Cohort of Hereditary Stomatocytoses and Other Channelopathies Affecting the Red Blood Cell
NCT04778657 ·Status: RECRUITING
-
Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
NCT06708728 ·Status: NOT_YET_RECRUITING
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
The Spleen in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00971698 ·Status: COMPLETED
-
Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
NCT00005307 ·Status: COMPLETED
-
Full Assessment of Clinical Transfusion Support
NCT07094646 ·Status: COMPLETED
-
Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital
NCT03273998 ·Status: UNKNOWN
-
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198 ·Status: UNKNOWN
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Thrombophilia In Beta Thalassemia
NCT04219449 ·Status: NOT_YET_RECRUITING
-
Invasive Infections in Children With Hemoglobinopathies
NCT00456443 ·Status: COMPLETED
-
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837 ·Status: COMPLETED
-
RBC Transfusion in Severe Anemia With Lactic Acidosis
NCT01586923 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Hypophosphataemia Following Intravenous Iron
NCT04502784 ·Status: UNKNOWN
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease
NCT04983654 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
NCT00354484 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.
NCT01160198 ·Status: COMPLETED ·Phase: PHASE3
-
Ferric Carboxymaltose Methemoglobinemia Study
NCT06958822 ·Status: COMPLETED
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
NCT04205266 ·Status: RECRUITING ·Phase: PHASE4
-
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
NCT02087553 ·Status: COMPLETED
-
Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia
NCT04968379 ·Status: WITHDRAWN ·Phase: PHASE2
-
Long Term Outcomes in β Thalassemia Major
NCT02307786 ·Status: COMPLETED